+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Nicotine Patch Market 2019-2023 - Product Image

Global Nicotine Patch Market 2019-2023

  • ID: 4756176
  • Report
  • Region: Global
  • 113 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline plc.
  • Novartis AG
  • Perrigo Company plc.
  • MORE
Organized retail channel has grown globally with the establishment of supermarkets, pharmacy stores, drugstores, convenience stores, hypermarkets, and specialty stores. Nicotine patches are primarily sold by organized retailers, as vendors are highly dependent on large organized retailers. Large organized retailers provide enhanced product visibility and wider accessibility to consumers. Supermarkets, hypermarkets, drugstores, and pharmacy stores constitute the major distribution channel for nicotine patches.

Considering the rise in population, rapid infrastructural developments, and growing urbanization, the demand for supermarkets, hypermarkets, and other organized retailing outlets is growing. Therefore, the increase in the number of organized retailing outlets that provide nicotine patches will drive the growth of the global nicotine patch market during the forecast period. The analysts have predicted that the nicotine patch market will register a CAGR of close to 7% by 2023.

Market Overview

Increasing number of new product launches

The increasing number of innovative and new product launches has been boosting the growth of the global nicotine patch market. The rise in demand for nicotine patch-based products in various countries has led vendors to continually launch innovative products to expand their customer base.

Stringent regulations

Players in the global a nicotine patch market must adhere to the stringent rules and regulations imposed by various government bodies in different countries to check the sale of tobacco products. The presence of stringent regulations pertaining to labeling, sales, and marketing of nicotine-based products can hinder the growth of the global nicotine patch market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the nicotine patch market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be highly concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline plc.
  • Novartis AG
  • Perrigo Company plc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • 24-hour nicotine patch - Market size and forecast 2018-2023
  • 16-hour nicotine patch - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • South America - Market size and forecast 2018-2023
  • MEA - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Online retailing
  • Rising number of promotional campaigns and activities for smoking cessation aids
  • Technological innovations in transdermal drug delivery process
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Perrigo Company plc
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global tobacco market
Exhibit 02: Segments of global tobacco market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global nicotine patch market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global nicotine patch market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: -hour nicotine patch - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: -hour nicotine patch - Year-over-year growth 2019-2023 (%)
Exhibit 21: -hour nicotine patch - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: -hour nicotine patch - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Comparison by geography
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 33: South America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: South America - Year-over-year growth 2019-2023 (%)
Exhibit 35: MEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: MEA - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Dr. Reddy’s Laboratories Ltd. - Vendor overview
Exhibit 46: Dr. Reddy’s Laboratories Ltd. - Business segments
Exhibit 47: Dr. Reddy’s Laboratories Ltd. - Organizational developments
Exhibit 48: Dr. Reddy’s Laboratories Ltd. - Geographic focus
Exhibit 49: Dr. Reddy’s Laboratories Ltd. - Segment focus
Exhibit 50: Dr. Reddy’s Laboratories Ltd. - Key offerings
Exhibit 51: GlaxoSmithKline plc. - Vendor overview
Exhibit 52: GlaxoSmithKline plc. - Business segments
Exhibit 53: GlaxoSmithKline plc. - Organizational developments
Exhibit 54: GlaxoSmithKline plc. - Geographic focus
Exhibit 55: GlaxoSmithKline plc. - Segment focus
Exhibit 56: GlaxoSmithKline plc. - Key offerings
Exhibit 57: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 58: Johnson & Johnson Services, Inc. - Business segments
Exhibit 59: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 60: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 61: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 62: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 63: Novartis AG - Vendor overview
Exhibit 64: Novartis AG - Business segments
Exhibit 65: Novartis AG - Organizational developments
Exhibit 66: Novartis AG - Geographic focus
Exhibit 67: Novartis AG - Segment focus
Exhibit 68: Novartis AG - Key offerings
Exhibit 69: Perrigo Company plc - Vendor overview
Exhibit 70: Perrigo Company plc - Business segments
Exhibit 71: Perrigo Company plc - Organizational developments
Exhibit 72: Perrigo Company plc - Geographic focus
Exhibit 73: Perrigo Company plc - Segment focus
Exhibit 74: Perrigo Company plc - Key offerings
Exhibit 75: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • GlaxoSmithKline plc.
  • Novartis AG
  • Perrigo Company plc.
  • MORE
Global Nicotine Patch Market 2019-2023

The analyst recognizes the following companies as the key players in the global nicotine patch market: Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising number of promotional campaigns and activities for smoking cessation aids.”

According to the report, one of the major drivers for this market is the benefits from using nicotine patches.

Further, the report states that one of the major factors hindering the growth of this market is the side effects of nicotine patches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Perrigo Company plc.
Note: Product cover images may vary from those shown
Adroll
adroll